Pressroom: Media Coverage

Showing 561 - 580 of 608 news items

2011

Colon Cancer Death Rates Falling Faster in Northeast Than in South

An American Cancer Society study found that colon cancer death rates have dropped considerably faster in the Northeast than in the South. Medical oncologist Leonard Saltz was quoted.

July 8, 2011
Lung Cancer Scans Can Be Unreliable: Study

A study published by lung cancer specialist Gregory Riely in the Journal of Clinical Oncology found that CT scans to measure lung tumors can be unreliable, potentially leading patients and doctors to believe the cancer is growing when it’s not.

July 8, 2011
Dr. Mark Kris Receives First ASCO Humanitarian Award

Thoracic oncologist Mark Kris was honored at the American Society of Clinical Oncology’s 2011 Annual Meeting with the first inaugural ASCO Humanitarian Award for his dedication and compassion in his professional work and volunteer efforts.

July 5, 2011
A Leg Up on Life

After a cancer diagnosis, Olympic hopeful Serena Burla has made a speedy recovery and her orthopaedic surgeon, Patrick Boland, is quoted.

July 1, 2011
Unveiling the Genetic Landscape of Ovarian Cancer

Ovarian cancer is difficult to detect early, and fewer than half of the 22,000 women diagnosed annually in the United States will live more than five years. Researchers released results of a massive hunt to track down the genetic changes that drive tumor growth in this dreaded disease. Gynecologic surgeon Douglas Levine is quoted.

June 29, 2011
Eyewitness News at 5: Benefits and Risks of Lung Cancer Screening

A recently published study found a benefit for screening longtime smokers for lung cancer. Pulmonologist and epidemiologist Peter Bach is quoted.

June 29, 2011
CBS Evening News - Saturday Edition

Executive Chef Pnina Peled discusses her love of food and Memorial Sloan Kettering’s efforts to please the palates of Memorial Sloan Kettering Cancer Center patients.

June 25, 2011
Battling Breast Cancer with Preventative Measures

A Long Island woman tells her story after finding out she has the BRCA1 gene mutation. Medical oncologist Kenneth Offit is mentioned.

June 20, 2011
Treatment May Help Ease Effect of Cancer

An experimental surgical procedure offers hope of a cure for one of the most dreaded side effects of breast cancer treatment — the arm pain that’s often caused by removing lymph nodes. Plastic surgeon Babak Mehrara is quoted.

June 20, 2011
The Today Show

The Today Show celebrated with several patients at the 2011 MSKCC Pediatric Convocation celebration. Two Memorial Sloan Kettering Cancer Center patients were profiled and pediatric oncologist Richard O’Reilly was interviewed.

June 20, 2011
Pleasantville's Sabety Beats Cancer with Music

Cancer survivor Ted Sabety discusses his battle with cancer at the Memorial Sloan Kettering Cancer Center Survivorship Dinner in Sleepy Hollow, NY.

June 14, 2011
Retinoblastoma Therapy Delivers Power of Chemotherapy with Surgical Precision

The past century has seen great strides in the treatment of retinoblastoma, with more than 95 percent of US patients now being cured of this rare childhood malignancy. Ophthalmic oncologist David Abramson is quoted.

June 8, 2011
Taking Chemo Drug Continuously Delayed Lung Cancer's Return

While most patients with advanced lung cancer take four courses of two chemotherapy drugs and then stop until recurrence occurs, continuing treatment with one of those drugs may delay return of the disease. Medical oncologist Mark Kris is quoted.

June 5, 2011
Study: Flaxseed Doesn't Reduce Women's Hot Flashes

A phase III trial showed that flaxseed did not significantly reduce hot flashes in postmenopausal women with or without breast cancer. Medical oncologist Mark Kris is quoted.

June 5, 2011
Roche's Avastin Shows Ovarian Cancer Benefit

A study led by gynecologic oncologist Carol Aghajanian showed the drug bevacizumab (Avastin®) delayed the progression of advanced ovarian cancer. She is quoted in the article.

June 5, 2011
Melanoma Drug Extends Life in Second Large Study

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Studies Find New Drugs Boost Skin Cancer Survival

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Two Drugs Shown to Prolong Survival in Advanced Melanoma Cases

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Drug Dramatically Helps Melanoma Patients

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Drugs Show Promise Slowing Advanced Melanoma

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011